硼替佐米对移植物抗宿主病的预防和治疗
摘要
硼替佐米以其独特的作用机制,良好的治疗效果引起了临床医师的关注。它不仅可以治疗多发性骨髓瘤(MM),而且可以预防和治疗移植物抗宿主病(GVHD)。因此,探讨硼替佐米预防和治疗GVHD的作用机理尤为重要。笔者就硼替佐米预防和治疗GVHD的作用机制进行综述。
出处
《国际输血及血液学杂志》
CAS
2012年第3期258-260,共3页
International Journal of Blood Transfusion and Hematology
参考文献17
-
1Koreth J,Stevenson KE,Kim HT,et al. Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors. Blood, 2009,114 (18) : 3956-3959.
-
2Groll M, Huber R. Substrate access and processing by the 20S proteasome core particle, Int J Biochem Cell Biol, 2003, 35(5): 606-616.
-
3Baumeister W, Walz J, ZiJhl F, et al. The proteasome:paradigm of a self-compartmentalizing protease. Cell, 1998, 92 (3): 367- 380.
-
4Palombella VJ, Rando OJ, Goldberg AL, et al. The ubiquitin- proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell, 1994,78 (5):773-785.
-
5Li X, Stark GR. NF kappaB-dependent signaling pathways. Exp Hematol, 2002, 30(4):285-296.
-
6Hideshima T, Mitsiades C, Akiyama M, et aL Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor P8-341. Blood, 2003, 101(4):1530-1534.
-
7Hideshima T, Chauhan D, Hayashi T, et al. Proteasome inhibitor PS-341 abrogates IL-6 triggered signaling cascades via caspase-dependent downregulation of gpl30 in multiple myeloma. Oncogene, 2003, 22(52):8386-8393.
-
8Landowski TH, Megli CJ, Nullmeyer KD, et al. Mitochondrial- mediated disregulation of Ca^2+ is a critical determinant of Veleade (PS-341/bortezomib) cytotoxieity in myeloma cell lines. Cancer Res, 2005, 65(9) :3828-3836.
-
9Ferrara JL, Levy R, Chao NJ. Pathophysiologic mechanisms of acute graft-versus-host disease. Biol Blood Marrow Transplant, 1999,5(6) :347-356.
-
10Finn PW, Stone JR, Boothby MR, et al. Inhibition of NF- kappaB-dependent T cell activation abrogates acute allograft rejection. J Immunol, 2001,167(10) :5994-6001.
-
1钱卫红,张德珍.1例肝移植术后移植物抗宿主病护理[J].护理研究(中旬版),2007,21(10):2721-2722. 被引量:3
-
2刘红,刘婷,李舰,曹华华,卢云清.1例肝移植术后移植物抗宿主病患者的护理[J].中华护理杂志,2007,42(5):418-419. 被引量:4
-
3张晓君,傅志仁,丁国善,王正昕,郭闻渊,施晓敏.肝移植后移植物抗宿主病继发自身免疫性溶血性贫血一例[J].中华肝胆外科杂志,2008,14(1):49-51. 被引量:1
-
4邓晓辉,梁辉,严云,郭若冰,朱杨,马静秋.移植物与受体T细胞的平衡对移植物抗宿主病影响的实验研究[J].上海医学,2005,28(4):312-314. 被引量:1
-
5李百泉.FK506:预防造血干细胞移植后移植物抗宿主病的新药[J].国外医学(输血及血液学分册),1999,22(6):399-401. 被引量:1
-
6费小明,陆化,汪承亚.骨髓间充质干细胞对骨髓移植后移植物抗宿主病和移植排斥的影响[J].国外医学(输血及血液学分册),2003,26(3):221-224. 被引量:1
-
7朱尊民,张琳,张鲁芳,郭建民,张茵.异基因移植CD56^+ CD16^+量对移植物抗宿主病影响[J].医药论坛杂志,2005,26(20):36-37.
-
8王利,谷振阳,赵小利,魏华萍,罗澜,赵莎莎,刘代红,王全顺,高春记.间充质干细胞对移植物抗宿主病预防作用的Meta分析[J].中国实验血液学杂志,2015,23(4):1125-1132. 被引量:5
-
9胡文兵,高清平,赵金涛,曾艳.骨髓间充质干细胞对急性淋巴细胞白血病小鼠骨髓移植后GVHD和GVL的影响[J].武汉大学学报(医学版),2005,26(5):588-591. 被引量:1
-
10周凤,彭文,邬洁明.再次肝移植术后急性移植物抗宿主病患者1例护理[J].上海护理,2011,11(1):88-90. 被引量:3